Spotlight Asset Group, Inc. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Spotlight Asset Group, Inc. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,000
+22.0%
20,0000.0%0.05%
+22.7%
Q2 2023$49,200
+35042.9%
20,0000.0%0.04%
-68.3%
Q1 2023$140
-99.9%
20,0000.0%0.14%0.0%
Q3 2022$140,000
-82.3%
20,000
-33.9%
0.14%
-64.8%
Q3 2021$793,000
-18.2%
30,2650.0%0.40%
+5.9%
Q2 2021$969,000
+12.0%
30,265
+23.2%
0.37%
+14.8%
Q1 2021$865,000
+18.8%
24,565
+8.2%
0.32%
+19.9%
Q4 2020$728,00022,7090.27%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders